---
title: "EPHX2"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Analysis of Gene EPHX2"
tags: ['GeneEPHX2', 'XenobioticMetabolism', 'CardiovascularDiseases', 'MetabolicDiseases', 'Cancer', 'DrugResponse', 'Mutation', 'TherapeuticStrategy']
---

# Analysis of Gene EPHX2

## Overview
Gene EPHX2 is located on chromosome 8 (8q21.11) and it is also known as epoxide hydrolase 2. This gene encodes an enzyme that plays a crucial role in the detoxification of various xenobiotics, such as environmental pollutants, dietary constituents, and drugs. 

## Function
The protein encoded by EPHX2 belongs to the epoxide hydrolase family, which is responsible for the hydrolysis of epoxides to less reactive diols. EPHX2 specifically catalyzes the hydrolysis of lipid epoxides, including unsaturated fatty acid epoxides and cholesterol epoxides. These epoxides are involved in the progression of atherosclerosis, hypertension, and various other chronic diseases. Therefore, EPHX2 is considered an important enzyme in the metabolism of xenobiotics and the regulation of cardiovascular and metabolic diseases.

## External IDs for Gene and Genomic Location, Aliases
- HGNC: 3384
- NCBI Entrez: 2053
- Ensembl: ENSG00000119793
- OMIM: 132811
- UniProtKB/Swiss-Prot: P34913
- Aliases: sEH, EPHX2, mEH

## AA Mutation List and Mutation Type with dbSNP ID
There are several amino acid (AA) mutations reported for EPHX2, including:
- Q62K, rs2282143
- K55R, rs2292596
- R287Q, rs4149056
- Y113H, rs751141

These mutations are categorized as single nucleotide polymorphisms (SNPs) and have been studied for their association with various cardiovascular and metabolic diseases.

## Somatic SNVs/InDels with dbSNP ID
There are several somatic SNVs/InDels reported for EPHX2, including:
- rs11571217
- rs28365063
- rs34794411
- rs59753680

These somatic mutations have been found in various cancers, such as breast, lung, and colorectal cancer.

## Related Disease
Studies have shown that EPHX2 is related to various diseases, including:
- Cardiovascular diseases (i.e., atherosclerosis, hypertension)
- Metabolic diseases (i.e., diabetes, obesity)
- Neurological diseases (i.e., Alzheimer’s disease)
- Cancer

## Treatment and Prognosis
There are currently no specific treatments available for EPHX2-associated diseases. However, some studies have suggested that inhibition of EPHX2 function may be a potential therapeutic strategy for the treatment of various diseases.

## Drug Response
Several drugs have been shown to affect the activity of EPHX2, including:
- Valproic acid
- Triclosan
- Rifampicin

## Related Papers
- Inhibition of soluble epoxide hydrolase as a potential treatment of cardiometabolic diseases: [Click](https://doi.org/10.1016/j.pharmthera.2018.11.008)
- EPHX2 gene polymorphisms and susceptibility to Alzheimer’s disease: [Click](https://doi.org/10.3233/JAD-2011-110469)
- Polymorphisms in EPHX2 and cardiovascular disease risk: a meta-analysis: [Click](https://doi.org/10.1007/s10495-017-1386-8)

Author: [Insert name]
Subject: Genetic Information Analyst
Note: The information provided is for educational purposes only and should not be used for diagnosis or treatment without consulting a healthcare professional.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**